These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35640044)

  • 21. Non-cryopreserved peripheral blood stem cells as a safe and effective alternative for autologous transplantation in multiple myeloma.
    Araújo AB; Soares TB; Schmalfuss T; Angeli MH; Furlan JM; Salton GD; Burin MM; Röhsig LM
    Transfusion; 2022 Oct; 62(10):1967-1972. PubMed ID: 36052689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved post-thaw recovery of peripheral blood stem/progenitor cells using a novel intracellular-like cryopreservation solution.
    Clarke DM; Yadock DJ; Nicoud IB; Mathew AJ; Heimfeld S
    Cytotherapy; 2009; 11(4):472-9. PubMed ID: 19499402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma.
    Wallington-Beddoe CT; Gottlieb DJ; Garvin F; Antonenas V; Sartor MM
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1386-93. PubMed ID: 19822297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution.
    Maurer K; Kim HT; Kuczmarski TM; Garrity HM; Weber A; Reynolds CG; Liney D; Cutler C; Antin JH; Koreth J; Ritz J; Shapiro RM; Romee R; Wu CJ; Soiffer RJ; Nikiforow S; Ho VT; Gooptu M
    Blood Adv; 2021 Dec; 5(23):5140-5149. PubMed ID: 34581754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-thaw viability of cryopreserved hematopoietic progenitor cell grafts: does it matter?
    Vrhovac R; Perić Z; Jurenec S; Kardum-Skelin I; Jelić-Puskarić B; Jaksić B
    Coll Antropol; 2010 Mar; 34(1):163-9. PubMed ID: 20432746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Impact of Cryopreservation on Hematopoietic Stem Cell Engraftment and Post-transplant Outcome During the COVID-19 Pandemic.
    Strzelec A; Gawlik-Rzemieniewska N; Klima A; Panek K; Helbig G
    In Vivo; 2024; 38(3):1271-1277. PubMed ID: 38688614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-thaw viable CD34(+) cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation.
    Lee S; Kim S; Kim H; Baek EJ; Jin H; Kim J; Kim HO
    Vox Sang; 2008 Feb; 94(2):146-52. PubMed ID: 18028260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cryopreserved versus fresh peripheral blood allogeneic stem cell transplantation outcomes in patients receiving post-transplant cyclophosphamide for graft-versus-host prophylaxis during the COVID-19 pandemic: a single center experience.
    Guo M; Liu J; Clark P; Ahmad S; Patel R; Varela JC; Mori S
    Int J Hematol; 2023 Mar; 117(3):428-437. PubMed ID: 36378406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allogeneic transplant procurement in the times of COVID-19: Quality report from the central European cryopreservation site.
    Wiercinska E; Schlipfenbacher V; Bug G; Bader P; Verbeek M; Seifried E; Bonig H
    J Transl Med; 2021 Apr; 19(1):145. PubMed ID: 33832504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity.
    Reich-Slotky R; Colovai AI; Semidei-Pomales M; Patel N; Cairo M; Jhang J; Schwartz J
    Vox Sang; 2008 May; 94(4):351-7. PubMed ID: 18179677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation.
    Rowley SD; Bensinger WI; Gooley TA; Buckner CD
    Blood; 1994 May; 83(9):2731-6. PubMed ID: 7513212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subsets of CD34+ hematopoietic progenitors and platelet recovery after high dose chemotherapy and peripheral blood stem cell transplantation.
    Meldgaard Knudsen L; Jensen L; Jarlbaek L; Hansen PG; Hansen SW; Drivsholm L; Nikolaisen K; Gaarsdal E; Johnsen HE
    Haematologica; 1999 Jun; 84(6):517-24. PubMed ID: 10366795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-World Experience of Cryopreserved Allogeneic Hematopoietic Grafts during the COVID-19 Pandemic: A Single-Center Report.
    Bankova AK; Caveney J; Yao B; Ramos TL; Bögeholz J; Heydari K; Diaz N; Jackson ML; Lowsky R; Brown JW; Johnston L; Rezvani AR; Frank MJ; Muffly L; Weng WK; Sidana S; Negrin RS; Miklos DB; Shiraz P; Meyer EH; Shizuru JA; Arai S
    Transplant Cell Ther; 2022 Apr; 28(4):215.e1-215.e10. PubMed ID: 35042013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cryopreservation of Growth Factor-Mobilized Peripheral Blood Stem Cells Does Not Compromise Major Outcomes after Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience.
    Connelly-Smith L; Gooley T; Roberts L; Mielcarek M; Linenberger M; Petersdorf E; Sandmaier BM; Milano F
    Transplant Cell Ther; 2023 Nov; 29(11):700.e1-700.e8. PubMed ID: 37659695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The importance of CD34+/CD33- cells in platelet engraftment after intensive therapy for cancer patients given peripheral blood stem cell rescue.
    Millar BC; Millar JL; Shepherd V; Blackwell P; Porter H; Cunningham D; Judson I; Treleaven J; Powles RL; Catovsky D
    Bone Marrow Transplant; 1998 Sep; 22(5):469-75. PubMed ID: 9733270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells.
    Morton J; Hutchins C; Durrant S
    Blood; 2001 Dec; 98(12):3186-91. PubMed ID: 11719353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients.
    Tricot G; Jagannath S; Vesole D; Nelson J; Tindle S; Miller L; Cheson B; Crowley J; Barlogie B
    Blood; 1995 Jan; 85(2):588-96. PubMed ID: 7529066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors that influence the collection and engraftment of allogeneic peripheral-blood stem cells in patients with hematologic malignancies.
    Brown RA; Adkins D; Goodnough LT; Haug JS; Todd G; Wehde M; Hendricks D; Ehlenbeck C; Laub L; DiPersio J
    J Clin Oncol; 1997 Sep; 15(9):3067-74. PubMed ID: 9294469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA; Sims-Poston L; Eldridge P; Hale GA
    Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy.
    Weaver CH; Hazelton B; Birch R; Palmer P; Allen C; Schwartzberg L; West W
    Blood; 1995 Nov; 86(10):3961-9. PubMed ID: 7579367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.